Pharmacotherapy in Dermatology - Acne, Psoriasis, Eczema and Other Skin Conditions
Tracking # 20-1395648
Course overview
1. Differentiate among common eczema subtypes, including seborrheic, discoid, and irritant eczema, and describe their clinical features. 2. Summarize the underlying pathophysiology and epidemiological trends of psoriasis, with attention to triggers and onset variations. 3. Implement individualized treatment plans for psoriasis, incorporating topical therapies, systemic agents, biologics, and phototherapy. 4. Identify pharmacologic options used to treat skin conditions such as rosacea, alopecia, pigmentation disorders, and skin infections. 5. Evaluate adverse effects, drug interactions, and long-term safety concerns of common dermatologic pharmacotherapies.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Registered Nurse
District of Columbia Board of Nursing
Registered Nurse
Florida Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Kansas State Board of Nursing
Registered Nurse
Michigan Board of Nursing
Registered Nurse
Mississippi Board of Nursing
Registered Nurse
New Hampshire Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
New Mexico Board of Nursing
Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Tennessee Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Wyoming Board of Nursing
Registered Nurse
Disclosure statements
eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content.
All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.